vimarsana.com

Page 3 - Lerner Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Xylitol: Common low-calorie sweetener linked to heart attack and stroke in study

Xylitol is used in many reduced-sugar foods and consumer products such as gum and toothpaste.

United statesNew yorkAndrew freemanMatthew tomeyStanley hazenCarla saundersDrug administrationWorld health organizationCalorie control councilAmerican heart associationLerner research instituteHuman healthNational jewish health in denverIcahn school of medicine at mount sinaiCleveland clinic centerCardiovascular diagnostics

Niacin Side Effects: Can Too Much Affect Your Heart?

Niacin, also known as vitamin B3, is critical to cell development, but too much may raise heart risks. Learn more about the effects of too much niacin.

United statesOffice of dietary supplementsCleveland clinic lerner research instituteNational institutes of healthDietary supplementsCleveland clinicLerner researchNational institutesIacin side effectsHeart healthCardiovascular riskIacin flushVitamin b3Niacin benefitsHat is niacin

Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology

/PRNewswire/ Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and.

Amit kumarSuparna mazumderAnixa biosciencesVincent tuohyJustin johnsonMike catelaniAnixa biosciences incNational cancer instituteDepartment of inflammationMoffitt cancer centerCleveland clinic lerner research instituteJapan patent officeInnovative breast cancer researchCleveland clinicCancer vaccinesOvarian cancer vaccines

Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine

/PRNewswire/ Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,.

United statesSan antonioMike catelaniAnixa biosciencesStephen kilmerAmit kumarG thomas buddVincent tuohyCleveland clinic lerner research instituteUs department of defenseInnovative breast cancer researchCleveland clinic cancer instituteDepartment of inflammationMoffitt cancer centerAnixa biosciences incCleveland clinic

Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine

/PRNewswire/ Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and.

United statesStephen kilmerAnixa biosciencesAxel ullrichMike catelaniJennifer davisBrian leyland jonesH michael shepardDennis slamonRobert weinbergVincent tuohyHarvard medical schoolInnovative breast cancer researchAnixa biosciences incDepartment of inflammationWarren alpert foundation prize

vimarsana © 2020. All Rights Reserved.